News | Breast Density | October 21, 2019

Densitas Breast Density Assessment Software Joins Nuance AI Marketplace

Partnership will provide access to artificial intelligence-powered breast density assessment to Nuance’s nationwide network of radiologists

Densitas Breast Density Assessment Software Joins Nuance AI Marketplace

October 21, 2019 — Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density assessment software will be available on the Nuance AI Marketplace. The company said the marketplace provides access to more than 70 percent of all radiologists across the largest network of connected healthcare facilities in the U.S.

Densitas densityai delivers fully automated, standardized and reproducible breast density assessments from standard DICOM (Digital Imaging and Communications in Medicine) clinical use images. Density assessments can be incorporated into risk models that evaluate patient-specific breast cancer risk. The artificial intelligence (AI)-powered densitas densityai solution is specifically designed to align with how the visual cortex processes breast images when radiologists visualize mammograms, and rapidly generates reproducible and standardized breast density assessments that line up with the American College of Radiology (ACR) Breast Imaging-Reporting and Data System) BI-RADS 5th ed. Atlas guidance on interpreting breast density from clinical use mammograms. Densitas recently announced that densitas densityai has been selected for use in a major breast screening trial in Germany.

"AI can play an important supporting role for radiologists by automating routine, time-consuming, subjective and fatiguing tasks so that they can focus on more challenging interpretive tasks," said Woojin Kim, M.D., chief medical information officer at the Healthcare Division of Nuance Communications. "What sets densitas densityai apart is that it has been thoughtfully designed to process routinely archived mammograms so that breast density assessments can be obtained from historical studies when comparing current with prior exams.  What I find compelling is that the density results are deeply embedded in the reporting workflow to deliver important information to radiologists at the time of interpretation while automatically populating the report."

Watch the VIDEO: The Role of Analytics in Value-Based Healthcare, an interview with Kim

Listen to the PODCAST: Why Blockchain Matters In Medical Imaging, an interview with Kim

For more information: www.densitas.health, www.nuance.com

Related Content

This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

Getty Images

News | Lung Imaging | September 15, 2021
September 15, 2021 — Revised guidelines for...
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Getty Images

Feature | Information Technology | September 14, 2021 | By Jef Williams
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.

Feature | Radiology Imaging | September 14, 2021 | By Brendon McHugh
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

Courtesy of Grand View Research

Feature | Magnetic Resonance Imaging (MRI) | September 14, 2021 | By Melinda Taschetta-Millane
Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated AI decision support tool for cardiac ultrasound.
News | Cardiovascular Ultrasound | September 14, 2021
September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S.
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh